269 related articles for article (PubMed ID: 29046486)
1. Synaptopodin is upregulated by IL-13 in eosinophilic esophagitis and regulates esophageal epithelial cell motility and barrier integrity.
Rochman M; Travers J; Abonia JP; Caldwell JM; Rothenberg ME
JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046486
[TBL] [Abstract][Full Text] [Related]
2. Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE).
Chandramouleeswaran PM; Shen D; Lee AJ; Benitez A; Dods K; Gambanga F; Wilkins BJ; Merves J; Noah Y; Toltzis S; Yearley JH; Spergel JM; Nakagawa H; Malefyt Rd; Muir AB; Wang ML
PLoS One; 2016; 11(3):e0150968. PubMed ID: 26992000
[TBL] [Abstract][Full Text] [Related]
3. LRRC31 is induced by IL-13 and regulates kallikrein expression and barrier function in the esophageal epithelium.
D'Mello RJ; Caldwell JM; Azouz NP; Wen T; Sherrill JD; Hogan SP; Rothenberg ME
Mucosal Immunol; 2016 May; 9(3):744-56. PubMed ID: 26462420
[TBL] [Abstract][Full Text] [Related]
4. IL-33 is induced in undifferentiated, non-dividing esophageal epithelial cells in eosinophilic esophagitis.
Travers J; Rochman M; Caldwell JM; Besse JA; Miracle CE; Rothenberg ME
Sci Rep; 2017 Dec; 7(1):17563. PubMed ID: 29242581
[TBL] [Abstract][Full Text] [Related]
5. Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.
Zeng C; Vanoni S; Wu D; Caldwell JM; Wheeler JC; Arora K; Noah TK; Waggoner L; Besse JA; Yamani AN; Uddin J; Rochman M; Wen T; Chehade M; Collins MH; Mukkada VA; Putnam PE; Naren AP; Rothenberg ME; Hogan SP
J Allergy Clin Immunol; 2018 Dec; 142(6):1843-1855. PubMed ID: 29729938
[TBL] [Abstract][Full Text] [Related]
6. Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis.
Vanoni S; Zeng C; Marella S; Uddin J; Wu D; Arora K; Ptaschinski C; Que J; Noah T; Waggoner L; Barski A; Kartashov A; Rochman M; Wen T; Martin L; Spence J; Collins M; Mukkada V; Putnam P; Naren A; Chehade M; Rothenberg ME; Hogan SP
J Allergy Clin Immunol; 2020 Jan; 145(1):239-254.e2. PubMed ID: 31647967
[TBL] [Abstract][Full Text] [Related]
7. Filaggrin and tight junction proteins are crucial for IL-13-mediated esophageal barrier dysfunction.
Wu L; Oshima T; Li M; Tomita T; Fukui H; Watari J; Miwa H
Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G341-G350. PubMed ID: 29746170
[TBL] [Abstract][Full Text] [Related]
8. Lysyl Oxidase Regulates Epithelial Differentiation and Barrier Integrity in Eosinophilic Esophagitis.
Sasaki M; Hara T; Wang JX; Zhou Y; Kennedy KV; Umeweni CN; Alston MA; Spergel ZC; Ishikawa S; Teranishi R; Nakagawa R; Mcmillan EA; Whelan KA; Karakasheva TA; Hamilton KE; Ruffner MA; Muir AB
Cell Mol Gastroenterol Hepatol; 2024; 17(6):923-937. PubMed ID: 38340809
[TBL] [Abstract][Full Text] [Related]
9. Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13.
Masuda MY; Pyon GC; Luo H; LeSuer WE; Putikova A; Dao A; Ortiz DR; Schulze AR; Fritz N; Kobayashi T; Iijima K; Klein-Szanto AJ; Shimonosono M; Flashner S; Morimoto M; Pai RK; Rank MA; Nakagawa H; Kita H; Wright BL; Doyle AD
J Allergy Clin Immunol; 2024 May; 153(5):1355-1368. PubMed ID: 38310974
[TBL] [Abstract][Full Text] [Related]
10. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
[TBL] [Abstract][Full Text] [Related]
11. Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis.
Rochman M; Travers J; Miracle CE; Bedard MC; Wen T; Azouz NP; Caldwell JM; Kc K; Sherrill JD; Davis BP; Rymer JK; Kaufman KM; Aronow BJ; Rothenberg ME
J Allergy Clin Immunol; 2017 Sep; 140(3):738-749.e3. PubMed ID: 28104354
[TBL] [Abstract][Full Text] [Related]
12. Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis.
Merves J; Chandramouleeswaran PM; Benitez AJ; Muir AB; Lee AJ; Lim DM; Dods K; Mehta I; Ruchelli ED; Nakagawa H; Spergel JM; Wang ML
PLoS One; 2015; 10(2):e0114831. PubMed ID: 25723478
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.
Arias Á; Lucendo AJ
Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):99-117. PubMed ID: 30791784
[TBL] [Abstract][Full Text] [Related]
14. Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation.
Simon D; Radonjic-Hösli S; Straumann A; Yousefi S; Simon HU
Allergy; 2015 Apr; 70(4):443-52. PubMed ID: 25620273
[TBL] [Abstract][Full Text] [Related]
15. Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype.
Manresa MC; Chiang AWT; Kurten RC; Dohil R; Brickner H; Dohil L; Herro R; Akuthota P; Lewis NE; Croft M; Aceves SS
Gastroenterology; 2020 Nov; 159(5):1778-1792.e13. PubMed ID: 32712105
[TBL] [Abstract][Full Text] [Related]
16. IL-13-induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis.
Marella S; Sharma A; Ganesan V; Ferrer-Torres D; Krempski JW; Idelman G; Clark S; Nasiri Z; Vanoni S; Zeng C; Dlugosz AA; Zhou H; Wang S; Doyle AD; Wright BL; Spence JR; Chehade M; Hogan SP
J Allergy Clin Immunol; 2023 Dec; 152(6):1550-1568. PubMed ID: 37652141
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis.
Avlas S; Shani G; Rhone N; Itan M; Dolitzky A; Hazut I; Grisaru-Tal S; Gordon Y; Shoda T; Ballaban A; Ben-Baruch NM; Rochman M; Diesendruck Y; Nahary L; Bitton A; Halpern Z; Benhar I; Varol C; Rothenberg ME; Munitz A
Allergy; 2023 Feb; 78(2):464-476. PubMed ID: 36070083
[TBL] [Abstract][Full Text] [Related]
18. Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.
Doyle AD; Masuda MY; Kita H; Wright BL
Front Immunol; 2020; 11():603295. PubMed ID: 33335531
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 9 Alters Epithelial Barrier and E-cadherin in Eosinophilic Esophagitis.
Doshi A; Khamishon R; Rawson R; Duong L; Dohil L; Myers SJ; Bell B; Dohil R; Newbury RO; Barrett KE; Kurten RC; Aceves SS
J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):225-231. PubMed ID: 30211842
[TBL] [Abstract][Full Text] [Related]
20. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis.
Sherrill JD; Kc K; Wu D; Djukic Z; Caldwell JM; Stucke EM; Kemme KA; Costello MS; Mingler MK; Blanchard C; Collins MH; Abonia JP; Putnam PE; Dellon ES; Orlando RC; Hogan SP; Rothenberg ME
Mucosal Immunol; 2014 May; 7(3):718-29. PubMed ID: 24220297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
